Evidence for synaptic stripping by cortical microglia

Recent studies have described significant demyelination and microglial activation in the cerebral cortex of brains from multiple sclerosis patients. To date, however, experimental models of cortical demyelination or cortical inflammation have not been extensively studied. In this report we describe focal cortical inflammation induced by stereotaxic injection of killed bacteria (BCG), followed 1 month later by subcutaneous injection of the same antigen, a protocol that overcomes the immune privilege of the cortex. Intracerebral BCG injection produced focal microglial activation at the injection site (termed acute lesion). Ten days after peripheral challenge (termed immune‐mediated lesion), larger areas and higher densities of activated microglia were found near the injection site. In both paradigms, activated microglia and/or their processes closely apposed neuronal perikarya and apical dendrites. In the immune‐mediated lesions, ∼45% of the axosomatic synapses was displaced by activated microglia. Upon activation, therefore, cortical microglial migrate to and strip synapses from neuronal perikarya. Since neuronal pathology was not a feature of either the acute or immune‐mediated lesion, synaptic stripping by activated microglia may have neuroprotective consequences. © 2006 Wiley‐Liss, Inc.

[1]  Steffen Jung,et al.  Control of microglial neurotoxicity by the fractalkine receptor , 2006, Nature Neuroscience.

[2]  K. Reymann,et al.  Microglia provide neuroprotection after ischemia , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[3]  R. Ransohoff,et al.  The many roles of chemokines and chemokine receptors in inflammation. , 2006, The New England journal of medicine.

[4]  W. Gan,et al.  ATP mediates rapid microglial response to local brain injury in vivo , 2005, Nature Neuroscience.

[5]  N. Hardingham,et al.  Nuclear Ca2+ and the cAMP Response Element-Binding Protein Family Mediate a Late Phase of Activity-Dependent Neuroprotection , 2005, The Journal of Neuroscience.

[6]  W. Streit Microglia and neuroprotection: implications for Alzheimer's disease , 2005, Brain Research Reviews.

[7]  H. Kettenmann,et al.  Physiology of microglial cells , 2005, Brain Research Reviews.

[8]  I. Bechmann,et al.  CXCR3-Dependent Microglial Recruitment Is Essential for Dendrite Loss after Brain Lesion , 2004, The Journal of Neuroscience.

[9]  H. Bading,et al.  The Yin and Yang of NMDA receptor signalling , 2003, Trends in Neurosciences.

[10]  A. Minagar,et al.  The role of macrophage/microglia and astrocytes in the pathogenesis of three neurologic disorders: HIV-associated dementia, Alzheimer disease, and multiple sclerosis , 2002, Journal of the Neurological Sciences.

[11]  C. Ikonomidou,et al.  Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury? , 2002, The Lancet Neurology.

[12]  B. Trapp,et al.  Axon Loss in the Spinal Cord Determines Permanent Neurological Disability in an Animal Model of Multiple Sclerosis , 2002, Journal of neuropathology and experimental neurology.

[13]  B. Trapp,et al.  Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions , 2001, Annals of neurology.

[14]  W. Ye,et al.  Monocyte chemoattractant protein-1 expressed in neurons and astrocytes during focal ischemia in mice , 2001, Brain Research.

[15]  R. Ransohoff,et al.  Monocyte chemoattractant protein (MCP)-1 is rapidly expressed by sympathetic ganglion neurons following axonal injury , 2001, Neuroreport.

[16]  M. Graeber,et al.  Neuronal MCP-1 Expression in Response to Remote Nerve Injury , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[17]  M. Wilhelm,et al.  Molecular and cellular events associated with ischemia/reperfusion injury. , 2000, Annals of transplantation.

[18]  W. Streit,et al.  Reactive microgliosis , 1999, Progress in Neurobiology.

[19]  J. Westwick,et al.  Chemokines and T lymphocytes: more than an attraction. , 1998, Immunity.

[20]  B. Rollins,et al.  Abnormalities in Monocyte Recruitment and Cytokine Expression in Monocyte Chemoattractant Protein 1–deficient Mice , 1998, The Journal of experimental medicine.

[21]  G. Kreutzberg Microglia: a sensor for pathological events in the CNS , 1996, Trends in Neurosciences.

[22]  Y. Imai,et al.  A novel gene iba1 in the major histocompatibility complex class III region encoding an EF hand protein expressed in a monocytic lineage. , 1996, Biochemical and biophysical research communications.

[23]  G. Tseng,et al.  Perineuronal microglial reactivity following proximal and distal axotomy of rat rubrospinal neurons , 1996, Brain Research.

[24]  S. Thanos,et al.  The concept of microglia in relation to central nervous system disease and regeneration , 1996, Progress in Neurobiology.

[25]  K. Barron The microglial cell. A historical review , 1995, Journal of the Neurological Sciences.

[26]  V. Perry,et al.  Demyelination in the central nervous system following a delayed-type hypersensitivity response to bacillus Calmette-Guérin , 1995, Neuroscience.

[27]  M. Mallat,et al.  Brain macrophages: neurotoxic or neurotrophic effector cells? , 1994, Journal of Leukocyte Biology.

[28]  R. Ransohoff,et al.  Astrocyte expression of mRNA encoding cytokines IP‐10 and JE/MCP‐1 in experimental autoimmune encephalomyelitis , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[29]  D. Giulian,et al.  Brain glia release factors with opposing actions upon neuronal survival , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[30]  D. Walker,et al.  Microglia in degenerative neurological disease , 1993, Glia.

[31]  T. Molitor,et al.  Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. , 1992, Journal of immunology.

[32]  G. Kreutzberg,et al.  Spinal cord microglia in experimental allergic neuritis. Evidence for fast and remote activation. , 1992, Laboratory investigation; a journal of technical methods and pathology.

[33]  K. Hossmann,et al.  Immunocytochemical Study of an Early Microglial Activation in Ischemia , 1992, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[34]  C. Théry,et al.  Cytotoxic Effect of Brain Macrophages on Developing Neurons , 1991, The European journal of neuroscience.

[35]  K. Barron,et al.  Perineuronal glial responses after axotomy of central and peripheral axons. A comparison , 1990, Brain Research.

[36]  S. Haga,et al.  Demonstration of microglial cells in and around senile (neuritic) plaques in the Alzheimer brain , 1989, Acta Neuropathologica.

[37]  D. Selkoe,et al.  Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease , 1989, Journal of Neuroimmunology.

[38]  Stanley J. Watson,et al.  The rat brain in stereotaxic coordinates (2nd edn) by George Paxinos and Charles Watson, Academic Press, 1986. £40.00/$80.00 (264 pages) ISBN 012 547 6213 , 1987, Trends in Neurosciences.

[39]  M. Graeber,et al.  Synaptic stripping in the human facial nucleus , 2004, Acta Neuropathologica.

[40]  G. Kreutzberg,et al.  Displacement of synaptic terminals from regenerating motoneurons by microglial cells , 2004, Zeitschrift für Zellforschung und Mikroskopische Anatomie.

[41]  T. Kitamoto,et al.  Ferritin immunohistochemistry as a marker for microglia , 2004, Acta Neuropathologica.

[42]  L. Resnick,et al.  Simultaneous detection of ferritin and HIV-1 in reactive microglia , 2004, Acta Neuropathologica.

[43]  G. Baltuch,et al.  Microglia as mediators of inflammatory and degenerative diseases. , 1999, Annual review of neuroscience.

[44]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .